LOS ANGELES, April 10, 2014 /PRNewswire/ — Verde Media Group Inc. (VMGI) is pleased to announce that it has entered into a licensing agreement through its subsidiary Beautyject, Inc. for the first ever needle-free injection technology adapted to the beauty care and cosmetic markets. As per the agreement Beautyject has the exclusive, perpetual rights to manufacture, market, distribute and sell the products in North, South and Central America.
Beautyject was founded with the mission to provide healthy, effective, skin care and wellness products designed to improve the skin and enhance appearance. Beautyject represents the intersection of where beauty meets technology. Designed to deliver skin care treatments comfortably, accurately and quickly, without the use of a needle, the company will provide clinical grade skin care products to assist physicians and aestheticians with their procedural skin care needs. In addition, Beautyject will also provide products for customers who choose not to have professional treatments, yet want the same results at home for healthier and younger looking skin.
The Beautyject technology can be used to administer selected liquid cosmetic products such as hyaluronic acid, vitamins and botox to the top layers of the skin through a non-invasive, needle-free, painless delivery system called the “Poring Method”. With approximately 5000 uses, consumers, physicians and beauticians can simply re-fill ampoules with their cosmetic treatment of choice. Replaceable adapters and a reusable transporter facilitate fast and easy transfer of the fluid from all the usual types of containers into a sterile ampoule.
The Company’s injectors are superior to conventional needles in many ways and provide benefits to both home users and practitioners. Previously unavailable for private use, individuals can now administer unique formulations to treat superficial lines, minor skin damage, fine wrinkles, moisture and skin elasticity all at the convenience of their homes with no risk of needle stick injuries and damage to the skin. Practitioners benefit from attracting new clientele, new upsell opportunities for existing treatments such as Botox, precision treatment delivery, increased client satisfaction and increased profitability due to complete emptying of ampoules and a longer shelf life.
Beautyject is in advanced discussions with an internationally recognized distribution group that has access to major broadcasting and satellite TV networks for the sale and distribution of its beauty products throughout North America. With an estimated size for the anti-aging industry of $240B, Beautyject expects revenues to reach upwards of $25 million in its first year of commercialization.
William Veve, President of Verde Media Group, Inc. stated, “Entering into the exclusive license agreement for this technology is the first step to rapid commercialization. We are very excited to be moving fast with Beautyject to deliver complete value to our shareholders.”
About Verde Media Group Inc.
Verde Media Group Inc. is a publicly traded company listed on the OTC Markets trading under the stock symbol: VMGI. Verde Media Group Inc. The Company consists of three divisions:
The innovative Agency division services- public relations, marketing, sales and transaction functions for corporate clientele. The agency is rapidly expanding its business in the Denver, Colorado market that will become the largest legal retail marijuana sector.
The VMBD division undertakes the business of developing and producing high value bio-products from renewable biomass. The focus and criterion is to develop proprietary microbial technologies with low risk scale-up methods employing low cost feedstock. VMBD will further develop the derivative and ester forms of THC for increase in potency and their use in different delivery systems, including sublingual, inhaled dosage forms and blending with food products.
The Company operates a managed media company with production, distribution, development, and acquisition functions for film and television.
DISCLAIMER: CAUTIONARY DISCLOSURE ABOUT FORWARD-LOOKING STATEMENTS
The results described herein cannot be guaranteed. This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements in this news release other than statements of historical fact are “forward-looking statements” that are based on current expectations and assumptions.